(Total Views: 497)
Posted On: 02/11/2020 9:43:34 PM
Post# of 145871
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
During the interview, I heard NP state that Vyera would be responsible for deciding what the price for leronlimab since they are the experts. I know there have to be guidelines when pricing, but that sounds like possible fuel for the bashers. I think it's important for CYDY to show we are in control of this product and not passing the torch when it comes to pricing. Especially with Vyera's history. Just a take away I had from interview.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)